department of pharmacology



Anthony P. Adamis, MD

VP, Global Head of Ophthalmology
Genentech, Inc.
1 DNA Way
South San Francisco, CA 94080

Anthony P. Adamis, M.D. is a co-founder of Eyetech Pharmaceuticals. From January 1998 to June 2002, Dr. Adamis was Associate Professor of Ophthalmology at Harvard Medical School . From 1992 to June 2002, Dr. Adamis served as Director of Residency Training in Ophthalmology at the Massachusetts Eye and Ear Infirmary, a teaching affiliate of Harvard Medical School . He also served as a principal investigator and co-director of the Retina Research Institute for Diabetic Retinopathy and Macular Degeneration at the Massachusetts Eye and Ear Infirmary. From January 2001 to December 2001, Dr. Adamis served as President of the Medical Staff and was a member of the board of directors of the Massachusetts Eye and Ear Infirmary. Dr. Adamis is a specialist in ocular vascular disease and ocular drug delivery. He co-discovered the role that VEGF plays in a new blood vessel growth and blood vessel leakage related to various diseases of the eye.

Dr. Adamis received his M.D. with Honors from the University of Chicago 's Pritzker School of Medicine and his undergraduate degree from the University of Illinois , Urbana . Dr. Adamis completed his ophthalmology residency training at the University of Michigan . Dr. Adamis is the author of more than 100 scientific articles concerning ophthalmic diseases.